Founded in 1885, the company is one of the largest pharmaceutical firms in the world, with a strong emphasis on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing.
Boehringer Ingelheim’s human pharmaceuticals division focuses on areas such as oncology, cardiovascular diseases, respiratory diseases, immunology, and diabetes. The company is known for its pioneering work in the development of biologic treatments, targeted therapies, and innovative drug delivery systems. It strives to address unmet medical needs by creating groundbreaking medicines that improve patient outcomes.
In addition to human health, Boehringer Ingelheim has a significant presence in animal health, producing vaccines, medications, and health products for livestock, pets, and other animals. The company’s research in this area supports the well-being of both domestic and agricultural animals, with a focus on preventing and treating diseases, enhancing productivity, and ensuring sustainable farming practices.
Boehringer Ingelheim operates globally, with a strong commitment to research and development (R&D), investing a significant portion of its revenue into advancing medical science. The company’s mission is to enhance quality of life by delivering innovative therapies and contributing to the global fight against diseases.
Our April Webinar is hosted by Tawuniya, Saudi Arabia’s largest and leading private insurer pioneering Value-Based Health Care (VBHC).
24 April 2025
09:00 EDT | 14:00 BST | 15:00 CEST | 17.00 Riyadh time
Presented By: Tawuniya
As healthcare systems shift from fee-for-service to value-based models, payers face the challenge of integrating VBHC principles to achieve better patient outcomes and cost-effective care. Discover how trusted partnerships with providers and mutual risk-sharing agreements can deliver higher quality care while driving value-based reimbursement.
What You Will Learn:
Don’t miss this opportunity to learn from industry leaders and gain practical insights into transforming healthcare financing with VBHC.
REGISTER NOW
![]() |
![]() |
|
---|---|---|
Dr Othman Al-Kassabi | Dr Mohammad Al-Saeed | |
CEO of Tawuniya | CEO of Health Sector Office |
![]() |
![]() |
|
---|---|---|
Dr Hadi Al-Enazy, | Dr Mohamed Kamal, | |
Senior Executive Director of Quality, | Medical Analytics Director | |
Governance and Transformation |
Seven Years of VBHC in Brazil: Lessons & Future Perspectives
27 March 2025
09:00 EST | 14:00 GMT | 15:00 CET | 11.00 BRASILIA
Presented By: Hospital Moinhos de Vento
Join our Knowledge Partner Hospital Moinhos de Vento (HMV), the pioneer in using the ICHOM framework to elevate patient outcomes in Brazil. Over the past seven years, HMV has implemented PROMs across nine diverse health conditions—from stroke and heart failure to cancers, orthopedic surgeries, neonatal care, and even COVID-19. Experts will share key insights on how these efforts have improved care quality, redesigned care pathways, and addressed challenges along the way.
In this webinar, you will learn:
Speakers
Mohammed Parrini,
Chief Executive Officer at Hospital Moinhos de Vento
Carisi Polanczyk,
Head of the Cardiology Service at Hospital Moinhos de Vento
Luiz Antonio Nasi
Chief Medical Officer at Hospital Moinhos de Vento
Arthur Pille
Attending Neurologist at Hospital Moinhos de Vento
Sheila Martins
Head of Neurology at Hospital Moinhos de Vento
Speakers
Zofia Das-Gupta (Moderator)
Senior Director, Outcomes Implementation & Accreditation
ICHOM
Sumalee Samakkanonthakan, RN, M.N.S. (Adult Nursing)
Manager of Center of Excellence Heart (CoE Heart)
Bangkok Hospital Pattaya
Transform your approach to cardiac surgery care by learning:
Highlights: